<DOC>
	<DOCNO>NCT02343458</DOCNO>
	<brief_summary>A chronic dosing ( 24 week ) study assess efficacy safety GFF MDI ; PT003 ) , FF MDI ; PT005 , GP MDI ; PT001 ) subject moderate severe COPD , compare placebo .</brief_summary>
	<brief_title>Study Assess Efficacy Safety PT003 , PT005 , PT001 Subjects With Moderate Very Severe COPD</brief_title>
	<detailed_description>A randomized , double-blind , chronic dosing ( 24 week ) , placebo-controlled , parallel group , multi-center study assess efficacy safety glycopyrronium formoterol fumarate inhalation aerosol ( GFF ; PT003 ) , formoterol fumarate inhalation aerosol ( FF ; PT005 ) , glycopyrronium inhalation aerosol ( GP ; PT001 ) subject moderate severe COPD , compare placebo .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>Nonchild bear potential ( ie , physiologically incapable become pregnant , include female 2 year postmenopausal ) ; Child bear potential , negative serum pregnancy test Visit 1 , agree acceptable contraceptive method use consistently correctly duration study . Subjects establish clinical history COPD define American Thoracic Society ( ATS ) /European Respiratory Society ( ERS ) . Current former smoker history least 10 packyears cigarette smoking . Forced expiratory volume 1 second/forced vital capacity ( FEV1/FVC ) ratio &lt; 0.70 . FEV1 must &lt; 80 % predict normal value calculate use Third National Health Nutrition Examination Survey ( NHANES III ) reference equation . ( Or reference norm applicable region ) . Significant disease COPD , ie , disease condition , opinion Investigator , may put subject risk participation study may influence either result study subject 's ability participate study . Women pregnant lactate woman childbearing potential use acceptable method contraception . Subjects , opinion Investigator , current diagnosis asthma . Subjects hospitalize due poorly control COPD within 3 month prior Visit 1 ( Screening ) Screening Period ( Visit 1 Visit 4 ) . Subjects poorly control COPD , define acute worsen COPD require treatment oral corticosteroid antibiotic within 6 week prior Visit 1 ( Screening ) Screening Period ( Visit 1 Visit 4 ) . Subjects diagnosis angle closure glaucoma exclude , regardless whether treat . Subjects diagnosis open angle glaucoma intraocular pressure control medication ( ) eligible . Subjects history hypersensitivity Î²2agonists , glycopyrronium muscarinic anticholinergic , component MDI .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>COPD</keyword>
</DOC>